sarah_TO said:

The GIP arm is doing real work rather than padding the label.

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

Clinical perspective, offered as context rather than as advice.

Before/after bloodwork compilation for the lipid panel — everything in one place for those who want comprehensive data:

Every single metabolic marker improved. This is why I'm a believer in this therapy.

DebRD_ATL said:

Steady state is faster than people expect: half-life about five days, so you are at plateau in roughly three to four weeks rather than five.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The "tirzepatide is simply better" summary irritates me. It is better on mean weight loss, and the cardiovascular outcome evidence is far thinner than semaglutide's. If the reason for treating is cardiovascular risk rather than weight, the evidence base points the other way.

Dr.LipidDallas said:

ApoB is the more informative number and it is cheap.

Tracking labs for the lipid panel — here's the panel I get every 3 months and why:

• CMP: glucose, electrolytes, kidney function, liver enzymes
• Lipid panel: total cholesterol, LDL, HDL, triglycerides
• A1C: 3-month glucose average
• hsCRP: inflammatory marker
• CBC: blood counts, anemia screening
• B12, folate, iron: nutritional deficiency screening
• TSH, free T4: thyroid monitoring
• Lipase: pancreatic safety check

Total cost with insurance: about $38 copay. Without insurance, request cash-pay pricing from Quest/Labcorp — usually $153.

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.